PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Hepatic & Biliary Function/AST
Hepatic & Biliary FunctionMitochondrial & Cytosolic Metabolism (Liver, Heart, Muscle)

Aspartate Aminotransferase (AST)

Aspartate aminotransferase exists in both mitochondrial (80%) and cytosolic (20%) isoenzyme forms across hepatocytes, cardiac myocytes, and skeletal muscle tissue.

Standard Range8 - 48 U/L
Optimal Longevity15 - 25 U/L
Measurement UnitU/L
Organ SystemMitochondrial & Cytosolic Metabolism (Liver, Heart, Muscle)
Routine Panels:CMPHepatic Function PanelMuscle Enzyme Screen

Standard vs. Optimal Reference RangesU/L

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: U/L
U/L
Presets:
5 U/LOptimal Zone Target65 U/L
Optimal Longevity Zone(20 U/L)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

8 - 48 U/L

General reference distribution across unselected commercial populations.

Optimal Longevity Target

15 - 25 U/L

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

AST catalyzes the conversion of aspartate and alpha-ketoglutarate into oxaloacetate and glutamate. While present in liver, high concentrations reside in cardiac and skeletal muscle, meaning intense resistance exercise frequently elevates AST independently of liver pathology.

Differential Diagnosis

Elevated Levels (AST High)

  • •Alcoholic liver disease (mitochondrial toxicity)
  • •Intense eccentric resistance training / Rhabdomyolysis
  • •Myocardial infarction
  • •Cirrhosis and advanced fibrosis

Low Levels (AST Low)

  • •Absence of tissue injury
  • •Vitamin B6 deficiency

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
Aspartate Aminotransferase (AST) reflects hepatocyte integrity, biliary canalicular transport, and hepatic synthetic capacity. Hepatic parenchymal cells synthesize proteins, metabolize xenobiotics via cytochrome P450 monooxygenases, and conjugate endogenous substrates via UDP-glucuronosyltransferases. Cellular membrane disruption from lipid peroxidation, bile acid toxicity, or immune-mediated cytolysis releases intracellular enzymes into systemic circulation. Synthesis rates of carrier proteins depend directly on ribosomal transcription and functional hepatic mass.
Longevity Risk Architecture & Epidemiology
Isolated elevations of AST without ALT rise usually point toward vigorous muscular training or rhabdomyolysis rather than hepatic dysfunction.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

A 12-hour overnight fast is recommended, especially if assessing biliary markers or lipid-associated hepatic enzymes. Complete abstinence from ethanol for at least 48 to 72 hours prior to testing is mandatory to prevent enzyme induction. Avoid strenuous unaccustomed weightlifting for 48 hours prior, which can release muscular transaminases and elevate AST/ALT.

Reflexive Testing Protocol:

  • Comprehensive Hepatic Viral Panel (Hepatitis A IgM, HBsAg, HBcAb, HCV antibody with reflex PCR)
  • Vibration-Controlled Transient Elastography (FibroScan) or Magnetic Resonance Elastography to quantify hepatic fat and fibrosis
  • Serum Ferritin and Total Iron-Binding Capacity (TIBC) to screen for hereditary hemochromatosis
  • Autoimmune Liver Disease Serology (Anti-Nuclear Antibodies, Anti-Smooth Muscle Antibodies, Anti-Mitochondrial Antibodies)
  • Abdominal Right Upper Quadrant Ultrasound to assess hepatic parenchyma, biliary ducts, and portal vein flow
Clinical Citations & Primary Literature (1)
  • [1]Clinical Interpretation of Liver Enzymes: AST, ALT, and GGT - American Journal of Gastroenterology (2021). PMID: 33417942
Common Panels:CMPHepatic Function PanelMuscle Enzyme Screen
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Aspartate Aminotransferase (AST) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Hepatic & Biliary Function Biomarkers

Alanine Aminotransferase
ALT · 12 - 25 U/L (Male: < 30 U/L, Female: < 20 U/L)
AST to ALT Ratio (De Ritis Ratio)
AST/ALT Ratio · 0.8 - 1.0 (with both enzymes in normal low range)
Gamma-Glutamyl Transferase
GGT · 10 - 20 U/L
PreviousAlanine Aminotransferase (ALT)Hepatic & Biliary FunctionNextAST to ALT Ratio (De Ritis Ratio) (AST/ALT Ratio)Hepatic & Biliary Function